{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:14:18Z","timestamp":1791317658951,"version":"4.3.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Glaucoma is a chronic neurodegenerative disease, which is the leading cause of irreversible blindness worldwide. As a response to high intraocular pressure, the clinical and molecular glaucoma biomarkers indicate the biological state of the visual system. Classical and uncovering novel biomarkers of glaucoma development and progression, follow-up, and monitoring the response to treatment are key objectives to improve vision outcomes. While the glaucoma imaging field has successfully validated biomarkers of disease progression, there is still a considerable need for developing new biomarkers of early glaucoma, that is, at the preclinical and initial glaucoma stages. Outstanding clinical trials and animal-model study designs, innovative technology, and analytical approaches in bioinformatics are essential tools to successfully uncover novel glaucoma biomarkers with a high potential for translation into clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To better understand the clinical and biochemical-molecular-genetic glaucoma pathogenesis, we conducted an analytical, observational, and case-comparative\/control study in 358 primary open-angle glaucoma (POAG) patients and 226 comparative-control individuals (CG) to collect tears, aqueous humor, and blood samples to be processed for identifying POAG biomarkers by exploring several biological pathways, such as inflammation, neurotransmitter\/neurotrophin alteration, oxidative stress, gene expression, miRNAs fingerprint and its biological targets, and vascular endothelial dysfunction, Statistics were done by using the IBM SPSS 25.0 program. Differences were considered statistically significant when <jats:italic>p<\/jats:italic> \u2264 0.05.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age of the POAG patients was 70.03 \u00b1 9.23 years, and 70.62 \u00b1 7.89 years in the CG. Malondialdehyde (MDA), nitric oxide (NO), interleuquin (IL)-6, endothelin-1 (ET-1), and 5 hydroxyindolacetic acid (5-HIAA), displayed significantly higher levels in the POAG patients vs. the CG (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Total antioxidant capacity (TAC), brain derived neurotrophic factor (BDNF), 5-hydroxy tryptamine (5-HT), solute carrier family 23-nucleobase transporters-member 2 (<jats:italic>SLC23A2<\/jats:italic>) gene, and the glutathione peroxidase 4 (<jats:italic>GPX4<\/jats:italic>) gene, showed significantly lower levelsin the POAG patients than in the CG (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The miRNAs that differentially expressed in tear samples of the POAG patients respect to the CG were the hsa miR-26b-5p (involved in cell proliferation and apoptosis), hsa miR-152-3p (regulator of cell proliferation, and extracellular matrix expression), hsa miR-30e-5p (regulator of autophagy and apoptosis), and hsa miR-151a-3p (regulator of myoblast proliferation).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>We are incredibly enthusiastic gathering as much information as possible on POAG biomarkers to learn how the above information can be used to better steer the diagnosis and therapy of glaucoma to prevent blindness in the predictable future. In fact, we may suggest that the design and development of blended biomarkers is a more appropriate solution in ophthalmological practice for early diagnosis and to predict therapeutic response in the POAG patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1157773","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T08:31:45Z","timestamp":1685089905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Biochemical\u2013molecular\u2013genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Maria D.","family":"Pinazo-Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Zan\u00f3n-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garc\u00eda\u2013Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Peris-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Vila-Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J.","family":"Garc\u00eda-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Andr\u00e9s\u2013Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gallego\u2013Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Garc\u00eda\u2013Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"B1","unstructured":"Terminology guidelines for glaucoma. 5th ed.2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/ICU.0000000000000461","article-title":"Recent developments in visual field testing for glaucoma","volume":"29","author":"Wu","year":"2018","journal-title":"Curr Opin Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.3390\/jcm10194414","article-title":"Global Glaucoma Staging System (GGSS): A New Method to Simultaneously Assess the Severity of Both Functional and Structural Damage in Glaucoma","volume":"10","author":"Brusini","year":"2021","journal-title":"J Clin Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/IJG.0000000000002083","article-title":"Primary Open Angle Glaucoma Prevalence in Europe: A Systematic Review and Meta-Analysis","volume":"31","author":"Gallo Afflitto","year":"2022","journal-title":"J Glaucoma."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.ophtha.2023.01.008","volume":"63","author":"Jackson","year":"2023","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6215745","article-title":"Eclectic ocular comorbidities and systemic diseases with eye involvement: a review","volume":"6215745","author":"Pinazo-Duran","year":"2016","journal-title":"Biomed Res Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/bs.pbr.2015.07.003","article-title":"Visual disability, and quality of life in glaucoma patients","volume":"221","author":"Cesareo","year":"2015","journal-title":"Prog Brain Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1001\/jama.2022.7531","article-title":"Screening for Primary Open-Angle Glaucoma","volume":"327","author":"Jin","year":"2022","journal-title":"JAMA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/ICU.0b013e3282f493b3","article-title":"Risk factors for primary open angle glaucoma progression: what we know and what we need to know","volume":"19","author":"Rivera","year":"2008","journal-title":"Curr Opin Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.maturitas.2022.05.002","article-title":"Glaucoma - risk factors and current challenges in the diagnosis of a leading cause of visual impairment","volume":"163","author":"Lee","year":"2022","journal-title":"Maturitas"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/jcm11195649","article-title":"Impact of systemic comorbidities on ocular hypertension and Open-Angle glaucoma, in a population from Spain and Portugal","volume":"11","author":"Garcia-Villanueva","year":"2022","journal-title":"J Clin Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.1073\/pnas.0405479101","article-title":"Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration","volume":"101","author":"Cordeiro","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pbr.2020.07.004","article-title":"The role of neuroinflammation in the pathogenesis of glaucoma neurodegeneration","volume":"256","author":"Pinazo-Dur\u00e1n","year":"2020","journal-title":"Prog Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3390\/jcm10153231","article-title":"Fully Automated Colorimetric Analysis of the Optic Nerve Aided by Deep Learning and Its Association with Perimetry and OCT for the Study of Glaucoma","volume":"10","author":"Gonzalez-Hernandez","year":"2021","journal-title":"J Clin Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"733080","DOI":"10.3389\/fmed.2021.733080","article-title":"Glaucoma clinical research: trends in treatment strategies and drug development","volume":"8","author":"Storgaard","year":"2021","journal-title":"Front Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/02713683.2018.1536218","article-title":"Nanotechnology-ocular devices for glaucoma treatment: a literature review","volume":"44","author":"Cardigos","year":"2019","journal-title":"Curr Eye Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00347-021-01368-7","article-title":"New therapeutic concepts in glaucoma treatment","volume":"118","author":"Erb","year":"2021","journal-title":"Ophthalmologe."},{"key":"B21","unstructured":"VecinoE.\n            SharmaS.C.\n          Glaucoma-basic clinical concepts2011"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.exer.2014.11.012","article-title":"Metabolomics of the aqueous humor in the rat glaucoma model induced by a series of intracamerular sodium hyaluronate injection","volume":"131","author":"Mayordomo-Febrer","year":"2015","journal-title":"Exp Eye Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2015.04.008","article-title":"Retinal neurodegeneration in experimental glaucoma","volume":"220","author":"Vidal-Sanz","year":"2015","journal-title":"Prog Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/medicina55060280","article-title":"Experimental models of glaucoma: a powerful translational tool for the future development of new therapies for glaucoma in humans-a review of the literature","volume":"55","author":"Evangelho","year":"2019","journal-title":"Medicina (Kaunas)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4103\/1673-5374.322454","article-title":"Retinal microglial activation in glaucoma: evolution over time in a unilateral ocular hypertension model","volume":"17","author":"Fernandez-Albarral","year":"2022","journal-title":"Neural Regen Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.63.5.2","article-title":"Sodium Hyaluronate-Induced Ocular Hypertension in Rats Damages the Direction-Selective Circuit and Inner\/Outer Retinal Plexiform Layers","volume":"63","author":"Noailles","year":"2022","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IJG.0b013e31815c3a7f","article-title":"Oxidative stress in primary open-angle glaucoma","volume":"17","author":"Zanon-Moreno","year":"2008","journal-title":"J Glaucoma"},{"key":"B28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.pbr.2015.06.001","article-title":"Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration","volume":"220","author":"Pinazo-Dur\u00e1n","year":"2015","journal-title":"Prog Brain Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2174\/1570159X15666170705101910","article-title":"Strategies to reduce oxidative stress in glaucoma patients","volume":"16","author":"Pinazo-Dur\u00e1n","year":"2018","journal-title":"Curr Neuropharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.06.001","article-title":"Autophagy in glaucoma: Crosstalk with apoptosis and its implications","volume":"117","author":"Wang","year":"2015","journal-title":"Brain Res Bull."},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog Retin Eye Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: From the back to the front of the eye, and beyond","author":"Baudouin","year":"2021","journal-title":"Prog Ret Eye Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/ICU.0000000000000245","article-title":"Vascular and autonomic dysregulation in primary open-angle glaucoma","volume":"27","author":"Pasquale","year":"2016","journal-title":"Curr Opin Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2110329119","DOI":"10.1073\/pnas.2110329119","article-title":"Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma","volume":"119","author":"Alarcon-Martinez","year":"2022","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2174\/1570159X16666180419121247","article-title":"Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects","volume":"16","author":"Chitranshi","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0169-328X(03)00030-5","article-title":"Glutamate stimulates neurotrophin expression in cultured M\u00fcller cells","volume":"111","author":"Taylor","year":"2003","journal-title":"Brain Res Mol Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jprot.2013.12.006","article-title":"Comparative proteomic study in serum of patients with primary open-angle glaucoma and pseudoexfoliation glaucoma","volume":"98","author":"Gonz\u00e1lez-Iglesias","year":"2014","journal-title":"J Proteomics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2015.11.032","article-title":"Candidate genes involved in the susceptibility of primary open angle glaucoma","volume":"577","author":"Kumar","year":"2016","journal-title":"Gene."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1038\/s41467-020-19865-9","article-title":"Quantification of purified endogenous miRNAs with high sensitivity and specificity","volume":"11","author":"Shin","year":"2020","journal-title":"Nat Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41598-017-01003-z","article-title":"Regulation of intraocular pressure by microRNA cluster miR-143\/145","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cellsig.2018.11.006","article-title":"Neuroprotective effects of overexpressed microRNA-200a on activation of glaucoma-related retinal glial cells and apoptosis of ganglion cells via downregulating FGF7-mediated MAPK signaling pathway","volume":"54","author":"Peng","year":"2019","journal-title":"Cell Signal."},{"key":"B42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1120672118795399","article-title":"Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study","volume":"29","author":"Benitez-Del-Castillo","year":"2018","journal-title":"Eur J Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000510211","article-title":"Tear 1H NMR-based metabolomics application to the molecular diagnosis of aqueous tear deficiency and Meibomian gland dysfunction","volume":"64","author":"Ben\u00edtez Del Castillo","year":"2020","journal-title":"Ophthalmic Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.preteyeres.2012.06.002","article-title":"Tear analysis in ocular surface diseases","volume":"31","author":"Zhou","year":"2012","journal-title":"Prog Retin Eye Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coph.2012.10.007","article-title":"Evaluation of presumptive biomarkers of oxidative stress, immune response, and apoptosis in primary open-angle glaucoma","volume":"13","author":"Pinazo-Dur\u00e1n","year":"2013","journal-title":"Curr Opin Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3164\/jcbn.08-162","article-title":"Efficient assay for total antioxidant capacity in human plasma using a 96-well microplate","volume":"44","author":"Kambayashi","year":"2009","journal-title":"J Clin Biochem Nutr."},{"key":"B47","doi-asserted-by":"publisher","first-page":"108941","DOI":"10.1016\/j.abb.2021.108941","article-title":"Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease","volume":"709","author":"Mas-Bargues","year":"2021","journal-title":"Arch Biochem Biophys."},{"key":"B48","first-page":"1841","article-title":"Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma","volume":"19","author":"Nucci","year":"2013","journal-title":"Mol Vis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.3390\/jcm9093032","article-title":"Computational analysis of clinical and molecular markers and new theranostic possibilities in primary open-angle glaucoma","volume":"9","author":"Pinazo-Dur\u00e1n","year":"2020","journal-title":"J Clin Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"106352","DOI":"10.1016\/j.eplepsyres.2020.106352","article-title":"Determination of levels of oxidative stress and nitrosative stress in patients with epilepsy","volume":"164","author":"Ersan","year":"2020","journal-title":"Epilepsy Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.bbagen.2012.05.012","article-title":"Correlation of serotonin levels in CSF, platelets, plasma, and urine","volume":"1820","author":"Audhya","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B52","first-page":"2953","article-title":"Smoking, an additional risk factor in elder women with primary open-angle glaucoma","volume":"15","author":"Zanon-Moreno","year":"2009","journal-title":"Mol Vis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.oftale.2020.03.003","article-title":"Aqueous humor interleukin-6 levels in primary open-angle glaucoma (POAG): A systematic review and meta-analysis","volume":"95","author":"Ulhaq","year":"2020","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2401976","DOI":"10.1155\/2016\/2401976","article-title":"Influence of endothelin-1 in aqueous humor on intermediate-term trabeculectomy outcomes","volume":"2016","author":"Choritz","year":"2016","journal-title":"J Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1272\/jnms.JNMS.2021_88-305","article-title":"Brain-derived neurotrophic factor in the aqueous humor of glaucoma patients","volume":"88","author":"Igarashi","year":"2021","journal-title":"J Nippon Med Sch."},{"key":"B56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/02713683.2011.556299","article-title":"Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients","volume":"39","author":"Goyal","year":"2014","journal-title":"Curr Eye Res."},{"key":"B57","first-page":"231","article-title":"Effects of polymorphisms in vitamin E-, vitamin C-, and glutathione peroxidase-related genes on serum biomarkers and associations with glaucoma","volume":"19","author":"Zanon-Moreno","year":"2013","journal-title":"Mol Vis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1261\/rna.036863.112","article-title":"Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing","volume":"19","author":"Burgos","year":"2013","journal-title":"RNA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cca.2019.05.028","article-title":"What information can be obtained from the tears of a patient with primary open angle glaucoma?","volume":"495","author":"Tamkovich","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/jcm10112227","article-title":"miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks","volume":"10","author":"Raga-Cervera","year":"2021","journal-title":"J Clin Med."},{"key":"B61","first-page":"37","article-title":"Open angle glaucoma: epidemiology, pathogenesis and prevention","volume":"97","author":"Izzotti","year":"2006","journal-title":"Recenti Prog Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0079-6123(08)01127-8","article-title":"Oxidative stress and glaucoma: injury in the anterior segment of the eye","volume":"173","author":"Sacc\u00e0","year":"2008","journal-title":"Prog Brain Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.optom.2017.06.002","article-title":"Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy","volume":"11","author":"McMonnies","year":"2018","journal-title":"J Optom."},{"key":"B64","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/CIA.S52662","article-title":"Oxidative stress and its downstream signaling in aging eyes","volume":"9","author":"Pinazo-Dur\u00e1n","year":"2014","journal-title":"Clin Interv Aging."},{"key":"B65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1167\/iovs.06-0810","article-title":"Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia","volume":"48","author":"Tezel","year":"2007","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1073\/pnas.1402819111","article-title":"Caspase-8 promotes NLRP1\/NLRP3 inflammasome activation and IL-1\u03b2 production in acute glaucoma","volume":"111","author":"Chi","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/eye.2017.241","article-title":"Inflammasomes, the eye and anti-inflammasome therapy","volume":"32","author":"Yerramothu","year":"2018","journal-title":"Eye (Lond)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.oftale.2018.01.001","article-title":"New horizons for the treatment of glaucoma. I: Neuroinflammation and inflammasomes","volume":"93","author":"Zanon-Moreno","year":"2018","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)."},{"key":"B69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","article-title":"Biomarkers of inflammation and oxidative stress in ophthalmic disorders","volume":"41","author":"Ahmad","year":"2020","journal-title":"J Immunoassay Immunochem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1152\/japplphysiol.00772.2016","article-title":"Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction","volume":"122","author":"Nishiyama","year":"2017","journal-title":"J Appl Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00467-021-05144-2","article-title":"Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescents","volume":"37","author":"Genovesi","year":"2022","journal-title":"Pediatr Nephrol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000323584","article-title":"Endothelin-1 and nitric oxide levels in patients with glaucoma","volume":"46","author":"Ghanem","year":"2011","journal-title":"Ophthalmic Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exer.2013.12.012","article-title":"Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility","volume":"120","author":"Dismuke","year":"2014","journal-title":"Exp Eye Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"R1288","DOI":"10.1152\/ajpregu.00397.2010","article-title":"The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives","volume":"300","author":"Bourque","year":"2011","journal-title":"Am J Physiol Reg Integ Comp Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"100767","DOI":"10.1016\/j.preteyeres.2019.06.003","article-title":"Cholinergic nervous system and glaucoma: From basic science to clinical applications","volume":"72","author":"Faiq","year":"2019","journal-title":"Prog Retin Eye Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1020993","DOI":"10.3389\/fmed.2022.1020993","article-title":"Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma","volume":"9","author":"Martucci","year":"2022","journal-title":"Front Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.yexmp.2011.01.001","article-title":"Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma","volume":"90","author":"Majsterek","year":"2011","journal-title":"Exp Mol Pathol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2982-6_1","article-title":"Detection of miRNAs","volume":"2630","author":"Bawazeer","year":"2023","journal-title":"Methods Mol Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/bio.2013.0060","article-title":"Collecting and preserving biological samples from challenging environments for DNA analysis","volume":"12","author":"Bu\u015b","year":"2014","journal-title":"Biopreserv Biobank."}],"updated-by":[{"DOI":"10.3389\/fmed.2025.1675008","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1157773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:31:52Z","timestamp":1755534712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1157773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":79,"alternative-id":["10.3389\/fmed.2023.1157773"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1157773","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fmed.2025.1675008","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"article-number":"1157773"}}